EuroSIDA Publications 2023
  1. Hepatitis delta infection among persons living with HIV in Europe. Béguelin C, Atkinson A, Boyd A, Falconer K, Kirkby N, Suter-Riniker F, Günthard HF, Rockstroh JK, Mocroft A, Rauch A, Peters L, Wandeler G; for EuroSIDA and SHCS.
    Liver Int. 2023;43(4):819-828. Abstract
  2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection. Surial B, Mena AR, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G; Swiss HIV Cohort Study, ATHENA Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
    J Hepatol. 2023:S0168-8278(23)00011-9. Epub ahead of print. Abstract
  3. Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study. Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem VN, Günthard HF, Zangerle R, Smith C, Castagna A, D Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group.
    Clin Infect Dis. 2023:ciad219. Epub ahead of print. Abstract

Total publications April 2023: 334